Evaluating the Hunger Project in Ghana

July 31, 2008 updated by: University of California, Berkeley

Evaluating the Hunger Project's Scaling-up of Epicenter Strategy in Ghana

The Hunger Project/Epicenter strategy is a community based development strategy that will positively affect health, education, empowerment, and consumption.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The investigators propose a randomized controlled design that will measure how The Hunger Projects' intervention affects the lives of Ghanaians. A pre-intervention baseline survey of approximately 4,000 households with over 20,000 individuals and two follow-up surveys of the same households will be conducted over the ten year experimental period.

Study Type

Interventional

Enrollment (Anticipated)

20000

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ghana
    • Eastern
      • Several, Eastern, Ghana
        • Recruiting
        • Ghana Hunger Project
        • Contact:
        • Principal Investigator:
          • David Levine, PhD Econ

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The subject population will be individuals and households from communities in the Eastern Region of Ghana.

Exclusion Criteria:

  • Only exclusion criteria is that households outside of the Eastern region of Ghana will not be surveyed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Increased sense of empowerment

Secondary Outcome Measures

Outcome Measure
Increased health, education, and consumption outcomes and increase in the number of public goods

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Berkeley

Collaborators

The Robertson Foundation

Investigators

  • Principal Investigator: David Levine, PhD Econ, University of California at Berkeley

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion

August 1, 2010

Study Completion (Anticipated)

May 1, 2016

Study Registration Dates

First Submitted

September 18, 2007

First Submitted That Met QC Criteria

September 18, 2007

First Posted (Estimate)

September 20, 2007

Study Record Updates

Last Update Posted (Estimate)

August 4, 2008

Last Update Submitted That Met QC Criteria

July 31, 2008

Last Verified

July 1, 2008

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CPHS Protocol #2007-4-42

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Community Empowerment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe